Amarin (AMRN) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

AMRN Stock Forecast

Amarin stock forecast is as follows: an average price target of $2.17 (represents a 389.18% upside from AMRN’s last price of $0.44) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

AMRN Price Target

The average price target for Amarin (AMRN) is $2.17 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $3.00 to $1.50. This represents a potential 389.18% upside from AMRN's last price of $0.44.

AMRN Analyst Ratings

Buy

According to 2 Wall Street analysts, Amarin's rating consensus is 'Buy'. The analyst rating breakdown for AMRN stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 0 'Hold' (0.00%), 1 'Sell' (50.00%), and 0 'Strong Sell' (0.00%).

Amarin Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jan 06, 2023		Jefferies	$3.00	$1.26	138.10%	576.28%
May 24, 2022		Goldman Sachs	$1.50	$1.41	6.38%	238.14%
May 05, 2022	Carl Byrnes	Northland Securities	$2.00	$1.56	28.21%	350.86%

The latest Amarin stock forecast, released on Jan 06, 2023 by Jefferies company, set a price target of $3.00, which represents a 138.10% increase from the stock price at the time of the forecast ($1.26), and a 576.28% increase from AMRN last price ($0.44).

Amarin Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$0.44	$0.44	$0.44
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of Amarin stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Amarin's last price of $0.44. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Jan 06, 2023	Jefferies		Buy	Upgrade
May 24, 2022	Goldman Sachs	Sell	Sell	Hold

Amarin's last stock rating was published by Jefferies on Jan 06, 2023. The company Upgrade its AMRN rating from "null" to "Buy".

Amarin Financial Forecast

Amarin Revenue Forecast

	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Mar 16
Revenue	-	-	-	-	-	-	-	$53.10M	$64.90M	$65.19M	$85.97M	$90.25M	$89.88M	$94.44M	$94.63M	$144.49M	$142.04M	$154.49M	$142.17M	$167.25M	$156.50M	$135.32M	$154.99M	$143.28M	$112.41M	$100.79M	$73.28M	$43.92M	$34.64M	$25.54M
Avg Forecast	$36.39M	$56.09M	$36.86M	$35.50M	$43.88M	$51.02M	$57.05M	$66.26M	$58.65M	$74.52M	$81.21M	$87.24M	$88.17M	$88.26M	$128.30M	$141.33M	$161.17M	$151.39M	$147.10M	$164.44M	$154.63M	$149.48M	$137.43M	$136.02M	$110.04M	$98.42M	$65.67M	$43.90M	$30.27M	$17.53M
High Forecast	$38.86M	$59.89M	$37.23M	$45.95M	$44.39M	$51.02M	$57.05M	$67.50M	$58.71M	$79.57M	$86.71M	$93.16M	$88.17M	$88.26M	$128.30M	$141.33M	$161.17M	$151.39M	$147.10M	$164.44M	$154.63M	$149.48M	$137.43M	$136.02M	$110.04M	$98.42M	$65.67M	$52.68M	$36.33M	$21.04M
Low Forecast	$34.38M	$52.99M	$36.50M	$27.50M	$43.37M	$51.02M	$57.05M	$65.01M	$58.58M	$70.40M	$76.72M	$82.42M	$88.17M	$88.26M	$128.30M	$141.33M	$161.17M	$151.39M	$147.10M	$164.44M	$154.63M	$149.48M	$137.43M	$136.02M	$110.04M	$98.42M	$65.67M	$35.12M	$24.22M	$14.03M
# Analysts	1	1	1	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	13	13	13	13	15	12	18
Surprise %	-	-	-	-	-	-	-	0.80%	1.11%	0.87%	1.06%	1.03%	1.02%	1.07%	0.74%	1.02%	0.88%	1.02%	0.97%	1.02%	1.01%	0.91%	1.13%	1.05%	1.02%	1.02%	1.12%	1.00%	1.14%	1.46%

Amarin's average Quarter revenue forecast for Mar 24 based on 1 analysts is $57.05M, with a low forecast of $57.05M, and a high forecast of $57.05M. AMRN's average Quarter revenue forecast represents a 7.43% increase compared to the company's last Quarter revenue of $53.10M (Dec 23).

Amarin EBITDA Forecast

	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Mar 16
# Analysts	1	1	1	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	13	13	13	13	15	12	18
EBITDA	-	-	-	-	-	-	-	$-16.66M	$-20.74M	$-13.93M	$-16.58M	$-6.95M	$2.62M	$-41.63M	$-27.53M	$16.43M	$2.32M	$9.68M	$-437.00K	$8.27M	$-5.39M	$5.71M	$-21.21M	$8.99M	$-1.64M	$84.00K	$-22.43M	$-21.59M	$-18.35M	$-23.00M
Avg Forecast	$-3.42M	$-5.27M	$-3.46M	$-3.33M	$-4.12M	$-4.79M	$-78.83M	$-6.22M	$-5.51M	$-7.00M	$-62.31M	$20.89M	$-5.45M	$-5.46M	$-49.26M	$-8.74M	$-9.96M	$-9.36M	$-754.19K	$-10.17M	$-9.56M	$-9.24M	$-24.23M	$-8.41M	$-6.80M	$-6.09M	$-35.40M	$-26.23M	$-19.81M	$-22.02M
High Forecast	$-3.23M	$-4.98M	$-3.43M	$-2.58M	$-4.07M	$-4.79M	$-63.06M	$-6.11M	$-5.50M	$-6.61M	$-49.85M	$25.07M	$-5.45M	$-5.46M	$-39.41M	$-8.74M	$-9.96M	$-9.36M	$-603.35K	$-10.17M	$-9.56M	$-9.24M	$-19.38M	$-8.41M	$-6.80M	$-6.09M	$-28.32M	$-20.98M	$-15.85M	$-17.61M
Low Forecast	$-3.65M	$-5.63M	$-3.50M	$-4.32M	$-4.17M	$-4.79M	$-94.59M	$-6.34M	$-5.52M	$-7.48M	$-74.78M	$16.71M	$-5.45M	$-5.46M	$-59.11M	$-8.74M	$-9.96M	$-9.36M	$-905.03K	$-10.17M	$-9.56M	$-9.24M	$-29.07M	$-8.41M	$-6.80M	$-6.09M	$-42.48M	$-31.48M	$-23.78M	$-26.42M
Surprise %	-	-	-	-	-	-	-	2.68%	3.76%	1.99%	0.27%	-0.33%	-0.48%	7.63%	0.56%	-1.88%	-0.23%	-1.03%	0.58%	-0.81%	0.56%	-0.62%	0.88%	-1.07%	0.24%	-0.01%	0.63%	0.82%	0.93%	1.04%

1 analysts predict AMRN's average Quarter EBITDA for Dec 22 to be $20.89M, with a high of $25.07M and a low of $16.71M. This is 698.46% upper than Amarin's previous annual EBITDA (Sep 22) of $2.62M.

Amarin Net Income Forecast

	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Mar 16
# Analysts	1	1	1	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	13	13	13	13	15	12	18
Net Income	-	-	-	-	-	-	-	$-5.78M	$-19.31M	$-17.56M	$-16.46M	$856.00K	$-5.14M	$-69.96M	$-31.56M	$14.70M	$-13.15M	$7.81M	$-1.63M	$4.93M	$-6.79M	$4.42M	$-20.55M	$7.07M	$-3.46M	$-1.82M	$-24.43M	$-24.09M	$-20.94M	$-29.77M
Avg Forecast	$-20.56M	$4.11M	$-24.67M	$-21.74M	$-22.84M	$-17.47M	$-90.91M	$-11.05M	$-18.50M	$-16.45M	$-71.87M	$12.44M	$-24.10M	$-26.15M	$-56.81M	$-6.86M	$-14.63M	$-13.52M	$-2.81M	$-6.62M	$2.18M	$-28.91M	$-23.49M	$-9.87M	$-20.40M	$-11.24M	$-33.31M	$-24.10M	$-17.91M	$-17.88M
High Forecast	$-19.08M	$4.47M	$-22.90M	$-14.49M	$-21.20M	$-16.22M	$-72.73M	$-5.53M	$-17.17M	$-15.26M	$-57.50M	$14.92M	$-24.10M	$-26.15M	$-45.45M	$-6.86M	$-14.63M	$-13.52M	$-2.24M	$-6.62M	$2.18M	$-28.91M	$-18.79M	$-9.87M	$-20.40M	$-11.24M	$-26.65M	$-19.28M	$-14.33M	$-14.30M
Low Forecast	$-22.37M	$3.82M	$-26.84M	$-28.98M	$-24.85M	$-19.01M	$-109.10M	$-13.82M	$-20.13M	$-17.90M	$-86.24M	$9.95M	$-24.10M	$-26.15M	$-68.18M	$-6.86M	$-14.63M	$-13.52M	$-3.37M	$-6.62M	$2.18M	$-28.91M	$-28.19M	$-9.87M	$-20.40M	$-11.24M	$-39.98M	$-28.92M	$-21.50M	$-21.46M
Surprise %	-	-	-	-	-	-	-	0.52%	1.04%	1.07%	0.23%	0.07%	0.21%	2.68%	0.56%	-2.14%	0.90%	-0.58%	0.58%	-0.74%	-3.11%	-0.15%	0.88%	-0.72%	0.17%	0.16%	0.73%	1.00%	1.17%	1.67%

Amarin's average Quarter net income forecast for Mar 23 is $-71.87M, with a range of $-86.24M to $-57.50M. AMRN's average Quarter net income forecast represents a -8495.91% decrease compared to the company's last Quarter net income of $856.00K (Dec 22).

Amarin SG&A Forecast

	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Mar 16
# Analysts	1	1	1	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	13	13	13	13	15	12	18
SG&A	-	-	-	-	-	-	-	$43.94M	$45.46M	$50.95M	$59.59M	$68.13M	$58.74M	$86.89M	$90.65M	$92.37M	$102.97M	$107.20M	$105.80M	$116.82M	$120.16M	$92.39M	$133.94M	$96.03M	$82.56M	$73.41M	$71.63M	$43.41M	$34.17M	$28.02M
Avg Forecast	$26.81M	$41.32M	$27.16M	$26.15M	$32.33M	$37.59M	$42.03M	$48.82M	$43.21M	$54.90M	$59.83M	$64.28M	$64.96M	$65.03M	$94.52M	$104.13M	$118.74M	$111.54M	$108.37M	$121.15M	$113.92M	$110.13M	$101.25M	$100.21M	$81.07M	$72.51M	$48.39M	$43.41M	$29.29M	$16.81M
High Forecast	$28.63M	$44.13M	$27.43M	$33.85M	$32.71M	$37.59M	$42.03M	$49.73M	$43.26M	$58.62M	$63.88M	$68.63M	$64.96M	$65.03M	$94.52M	$104.13M	$118.74M	$111.54M	$108.37M	$121.15M	$113.92M	$110.13M	$101.25M	$100.21M	$81.07M	$72.51M	$48.39M	$52.09M	$35.15M	$20.17M
Low Forecast	$25.33M	$39.04M	$26.89M	$20.26M	$31.95M	$37.59M	$42.03M	$47.90M	$43.16M	$51.87M	$56.52M	$60.72M	$64.96M	$65.03M	$94.52M	$104.13M	$118.74M	$111.54M	$108.37M	$121.15M	$113.92M	$110.13M	$101.25M	$100.21M	$81.07M	$72.51M	$48.39M	$34.73M	$23.43M	$13.45M
Surprise %	-	-	-	-	-	-	-	0.90%	1.05%	0.93%	1.00%	1.06%	0.90%	1.34%	0.96%	0.89%	0.87%	0.96%	0.98%	0.96%	1.05%	0.84%	1.32%	0.96%	1.02%	1.01%	1.48%	1.00%	1.17%	1.67%

Amarin's average Quarter SG&A projection for Mar 24 is $42.03M, based on 1 Wall Street analysts, with a range of $42.03M to $42.03M. The forecast indicates a -4.35% fall compared to AMRN last annual SG&A of $43.94M (Dec 23).

Amarin EPS Forecast

	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Mar 16
# Analysts	1	1	1	3	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	13	13	13	13	15	12	18
EPS	-	-	-	-	-	-	-	$-0.01	$-0.05	$-0.04	$-0.04	-	$-0.01	$-0.18	$-0.08	$0.04	$-0.03	$0.02	$-0.00	$0.01	$-0.02	$0.01	$-0.06	$0.02	$-0.01	$-0.01	$-0.08	$-0.09	$-0.09	$-0.16
Avg Forecast	$-0.05	$0.01	$-0.06	$-0.05	$-0.06	$-0.04	$-0.03	$-0.03	$-0.04	$-0.04	$-0.03	$-0.01	$-0.06	$-0.06	$-0.01	$-0.02	$-0.04	$-0.03	$-0.05	$-0.02	$0.01	$-0.07	$-0.07	$-0.02	$-0.05	$-0.03	$-0.11	$-0.08	$-0.06	$-0.07
High Forecast	$-0.05	$0.01	$-0.06	$-0.04	$-0.05	$-0.04	$-0.03	$-0.01	$-0.04	$-0.04	$-0.03	$-0.01	$-0.06	$-0.06	$-0.01	$-0.02	$-0.04	$-0.03	$-0.05	$-0.02	$0.01	$-0.07	$-0.07	$-0.02	$-0.05	$-0.03	$-0.11	$-0.06	$-0.05	$-0.05
Low Forecast	$-0.05	$0.01	$-0.07	$-0.07	$-0.06	$-0.05	$-0.03	$-0.03	$-0.05	$-0.04	$-0.03	$-0.01	$-0.06	$-0.06	$-0.01	$-0.02	$-0.04	$-0.03	$-0.05	$-0.02	$0.01	$-0.07	$-0.07	$-0.02	$-0.05	$-0.03	$-0.11	$-0.10	$-0.07	$-0.08
Surprise %	-	-	-	-	-	-	-	0.53%	1.05%	1.08%	1.37%	-0.25%	0.22%	2.83%	5.29%	-2.22%	0.93%	-0.61%	0.08%	-0.62%	-3.28%	-0.14%	0.85%	-0.83%	0.20%	0.40%	0.75%	1.15%	1.44%	2.29%

According to 1 Wall Street analysts, Amarin's projected average Quarter EPS for Mar 23 is $-0.03, with a low estimate of $-0.03 and a high estimate of $-0.03. This represents a -1505.38% decrease compared to AMRN previous annual EPS of - (Dec 22).

Amarin Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
AMRN	Amarin	$0.47	$2.17	361.70%	Buy
BIIB	Biogen	$150.64	$251.82	67.17%	Buy
GSK	GSK	$34.23	$53.00	54.83%	Hold
MRK	Merck	$100.06	$135.83	35.75%	Buy
AZN	AstraZeneca	$67.18	$88.00	30.99%	Buy
AMGN	Amgen	$265.95	$338.22	27.17%	Buy
SNY	Sanofi	$48.94	$62.00	26.69%	Buy
NVS	Novartis	$99.10	$120.50	21.59%	Hold
ABBV	AbbVie	$175.38	$211.20	20.42%	Buy
JNJ	Johnson & Johnson	$146.41	$175.13	19.62%	Buy
GILD	Gilead Sciences	$92.80	$87.30	-5.93%	Buy
BMY	Bristol-Myers Squibb Company	$57.65	$50.50	-12.40%	Hold

AMRN Forecast FAQ

Is Amarin a good buy?

Yes, according to 2 Wall Street analysts, Amarin (AMRN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of AMRN's total ratings.

What is AMRN's price target?

Amarin (AMRN) average price target is $2.17 with a range of $1.5 to $3, implying a 389.18% from its last price of $0.444. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Amarin stock go up soon?

According to Wall Street analysts' prediction for AMRN stock, the company can go up by 389.18% (from the last price of $0.444 to the average price target of $2.17), up by 576.28% based on the highest stock price target, and up by 238.14% based on the lowest stock price target.

Can Amarin stock reach $1?

AMRN's average twelve months analyst stock price target of $2.17 supports the claim that Amarin can reach $1 in the near future.

What are Amarin's analysts' financial forecasts?

AMRN's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $187.44M (high $198.4M, low $178.93M), average EBITDA is $-91.078M (high $-74.513M, low $-108M), average net income is $-153M (high $-125M, low $-182M), average SG&A $138.1M (high $146.17M, low $131.83M), and average EPS is $-0.181 (high $-0.154, low $-0.21).

Did the AMRN's actual financial results beat the analysts' financial forecasts?

Based on Amarin's last annual report (Dec 2023), the company's revenue was $285.3M, beating the average analysts forecast of $280.63M by 1.66%. Apple's EBITDA was $-67.588M, missing the average prediction of $-81.05M by -16.61%. The company's net income was $-59.112M, missing the average estimation of $-118M by -49.85%. Apple's SG&A was $199.94M, missing the average forecast of $206.75M by -3.30%. Lastly, the company's EPS was $-0.15, beating the average prediction of $-0.141 by 6.08%. In terms of the last quarterly report (Dec 2023), Amarin's revenue was $53.1M, missing the average analysts' forecast of $66.26M by -19.86%. The company's EBITDA was $-16.655M, beating the average prediction of $-6.225M by 167.57%. Amarin's net income was $-5.781M, missing the average estimation of $-11.054M by -47.70%. The company's SG&A was $43.94M, missing the average forecast of $48.82M by -9.99%. Lastly, the company's EPS was $-0.0142, missing the average prediction of $-0.0269 by -47.18%